Real Chemistry Executive and Leadership Team

Jeffrey Lupinacci, the Chief Financial Officer at Real Chemistry, manages all financial operations and strategic fiscal planning. Lupinacci oversees budgeting, forecasting, and financial reporting, ensuring robust fiscal health and supporting the company's growth objectives. This critical role involves managing investments, optimizing capital allocation, and maintaining strong relationships with financial stakeholders. By implementing rigorous financial controls and driving efficiency, Jeffrey Lupinacci directly contributes to the company's profitability and long-term sustainability. The Chief Financial Officer ensures that financial strategies are integrated with the overall business plan, supporting the creation of AI-powered healthcare experiences and driving commercial success for clients.

Jeffrey O'Connell, the Chief Operating Officer & Chief Technology Officer at Real Chemistry, directs both operational efficiency and technological innovation. O'Connell oversees the integration of AI technologies into the company's service offerings, ensuring seamless delivery of healthcare experiences. This dual role involves managing day-to-day operations, optimizing workflows, and driving the development of cutting-edge technological solutions. By fostering a culture of continuous improvement and technological advancement, Jeffrey O'Connell directly enhances the company's ability to serve its clients. The Chief Operating Officer & Chief Technology Officer ensures that operational processes and technological infrastructure effectively support Real Chemistry's mission to drive commercial success in the healthcare sector.

Jj Schmuckler, the Group President and Chief Revenue Officer at Real Chemistry, spearheads revenue generation and client acquisition strategies. Schmuckler drives commercial growth by identifying new market opportunities and expanding existing client relationships, focusing on AI-powered healthcare solutions. This leadership position involves managing sales teams, developing go-to-market plans, and ensuring revenue targets are met and exceeded. By fostering strong client partnerships and delivering exceptional value, Jj Schmuckler directly impacts Real Chemistry's financial performance. The Group President and Chief Revenue Officer ensures that the company's innovative offerings translate into tangible commercial success for healthcare organizations.

Christine Abbott, the President at Real Chemistry, provides strategic leadership and oversight across key business units. Abbott focuses on enhancing the company's market position by driving the development and implementation of AI-powered healthcare experiences. This executive role involves guiding strategic initiatives, fostering cross-functional collaboration, and ensuring operational excellence. By championing the company's vision and values, Christine Abbott directly contributes to Real Chemistry's sustained growth and impact. The President ensures that all organizational efforts align with the mission to create customer-centric healthcare solutions that drive commercial success for clients.

Kevin Johnson, the Group President and Managing Partner at Real Chemistry, leads strategic partnerships and client engagement initiatives. Johnson focuses on cultivating deep relationships with healthcare organizations, ensuring the effective deployment of AI-driven solutions. This role involves overseeing key accounts, driving business development, and ensuring client satisfaction through innovative healthcare experiences. By fostering collaboration and delivering strategic guidance, Kevin Johnson directly enhances Real Chemistry's market influence. The Group President and Managing Partner ensures that the company's expertise translates into measurable commercial success and improved patient outcomes for clients.

Shoreen Maghame, the President & Communications & Corporate Strategy Executive at Real Chemistry, directs strategic communications and corporate planning. Maghame shapes the company's narrative and strategic direction, ensuring alignment with its mission to drive healthcare commercial success through AI-powered experiences. This executive function involves overseeing internal and external communications, developing long-term strategic roadmaps, and managing corporate reputation. By integrating communication strategies with overarching business objectives, Shoreen Maghame directly strengthens Real Chemistry's market presence. The President & Communications & Corporate Strategy Executive ensures that the company's vision is clearly articulated and effectively executed across all platforms.

Kath Harrison, the Group President, International Growth at Real Chemistry, spearheads expansion into global markets. Harrison drives the adoption of AI-powered healthcare experiences across diverse international regions, focusing on commercial success for clients worldwide. This leadership role involves developing and executing international market entry strategies, managing regional teams, and adapting service offerings to local needs. By identifying and capitalizing on global opportunities, Kath Harrison directly contributes to Real Chemistry's worldwide reach. The Group President, International Growth ensures that the company's innovative solutions are effectively deployed to meet the unique challenges and demands of the international healthcare landscape.

Cali Howitt, the President, Medical Communications (US) at Real Chemistry, leads the strategic direction of medical communications within the United States. Howitt focuses on leveraging AI and data-driven insights to enhance communication strategies for healthcare clients, driving commercial success. This executive position involves overseeing the development and execution of impactful communication campaigns, managing client relationships, and ensuring the highest standards of scientific accuracy and engagement. By optimizing medical communication efforts, Cali Howitt directly supports the company's mission to create customer-centric healthcare experiences. The President, Medical Communications (US) ensures that US-based clients receive unparalleled strategic support and innovative solutions.

Marian James, the President, Analytics & Insights (Social Insights, Market Research, Measurement, Real World Data) at Real Chemistry, directs the company's advanced analytics and insights division. James leverages AI and comprehensive data sets, including social insights, market research, and real-world data, to drive commercial success for healthcare clients. This leadership role involves overseeing the generation of actionable intelligence, developing sophisticated measurement frameworks, and ensuring the strategic application of data to client challenges. By transforming complex data into clear insights, Marian James directly enhances the value proposition of Real Chemistry's AI-powered solutions. The President, Analytics & Insights ensures that clients receive data-driven strategies that optimize their market performance and customer engagement.

Ericka McKenna, the Chief Marketing Officer at Real Chemistry, directs all marketing initiatives, focusing on creating AI-powered, idea-driven healthcare experiences. McKenna architects brand strategy and market positioning, ensuring alignment with the company's core mission of driving commercial success for healthcare clients. This leadership role involves overseeing digital marketing, content creation, and public relations efforts to enhance customer engagement and market penetration. By optimizing campaign performance and analyzing market trends, Ericka McKenna directly influences the company's growth trajectory. The Chief Marketing Officer ensures that all external communications accurately reflect Real Chemistry's commitment to innovation and customer-centricity, driving impactful market presence.